I’ve never been a huge fan of mystery novels or the like. And really, the same has usually been true of real life mysteries as well. But I have always been intrigued by the mystery of health and biology. Medical research is something that never ceases to amaze. But I found myself suddenly enraptured by a real life mystery when medical research and banking came together within a single courtroom.
An investment bank by the name of Laidlaw & Company is currently in a legal fight against one of their former clients, Relmada Therapeutics. Additionally, it’s been contentious enough that the judge actually issued a temporary restraining order and associated injunction against Laidlaw. Saying that it sounds like an eventful case would be an understatement. And few things catch my attention like being told I’m not allowed to hear the other side of a story. This combined with the fact that medical research was involved prompted me to start investigating further.
I assumed the best place to start is with the party which had been silenced. So I loaded up Laidlaw’s website. The information there really did make me rethink my opinions about the case, Laidlaw, and even about medical research in general. One of the biggest reasons is simply the fact that it put so much of a human face on things. The site itself detailed a bank whose history dates all the way back to 1842. Even if one added a hundred years onto that it’d be a fairly well established institution.
But the real deciding factor for me was the human angle. Two of Laidlaw’s executives had quite a bit of exposure on the site. Matthew Eitner and James Ahern both had some detailed and even rather person information open to the public. And I feel like it shows them as people with a very firm sense of social responsibility and ethical concerns. They both have a strong history of charitable work and professional investments within the medical industry. The fact that good people head Laidlaw gave me a very positive impression of the company as a whole.